Valproic acid considerations Topical valproic acid has a different safety profile than oral valproic acid
Studies in patients with type 2 diabetes show that combining metformin with GLP-1 drugs produces greater HbA1c reductions than either agent alone
It does cover them for type 2 diabetes and, in specific cases, for cardiovascular risk reduction in patients with obesity and established heart disease
Clinical decisions remain the responsibility of the prescriber
Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC et al
If were going to inject something into our bodies, then some influencer on TikTok swears by it probably shouldnt be the deciding factor